Remy Sukhija
Net Worth

Last updated:

What is Remy Sukhija net worth?

The estimated net worth of Mr. Remy Sukhija is at least $10,407,273 as of 23 Dec 2022. He owns shares worth $38,500 as insider, has earned $8,224,073 from insider trading and has received compensation worth at least $2,144,700 in Madrigal Pharmaceuticals, Inc..

What is the salary of Remy Sukhija?

Mr. Remy Sukhija salary is $714,900 per year as Senior Vice President & Chief Commercial Officer in Madrigal Pharmaceuticals, Inc..

How old is Remy Sukhija?

Mr. Remy Sukhija is 53 years old, born in 1972.

What stocks does Remy Sukhija currently own?

As insider, Mr. Remy Sukhija owns shares in one company:

Company Title Shares Price per share Total value
Madrigal Pharmaceuticals, Inc. (MDGL) Senior Vice President & Chief Commercial Officer 100 $385 $38,500

What does Madrigal Pharmaceuticals, Inc. do?

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Remy Sukhija insider trading

Madrigal Pharmaceuticals, Inc.

Mr. Remy Sukhija has made 18 insider trades in 2022, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 60,000 units of MDGL stock on 23 Dec 2022. As of 23 Dec 2022 he still owns at least 100 units of MDGL stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 60,000 $60.26 $3,615,600
Sale
Common Stock 100 $284.65 $28,465
Sale
Common Stock 400 $283.43 $113,372
Sale
Common Stock 400 $282.13 $112,852
Sale
Common Stock 1,000 $280.92 $280,920
Sale
Common Stock 2,620 $279.96 $733,495
Sale
Common Stock 3,003 $279.15 $838,287
Sale
Common Stock 700 $277.83 $194,481
Sale
Common Stock 700 $276.67 $193,669
Sale
Common Stock 811 $275.7 $223,593
Sale
Common Stock 3,019 $274.56 $828,897
Sale
Common Stock 2,471 $273.54 $675,917
Sale
Common Stock 5,534 $272.68 $1,509,011
Sale
Common Stock 2,084 $271.54 $565,889
Sale
Common Stock 2,069 $270.56 $559,789
Sale
Common Stock 1,476 $269.61 $397,944
Sale
Common Stock 1,913 $268.5 $513,641
Sale
Common Stock 1,107 $267.47 $296,089
Sale
Common Stock 593 $266.04 $157,762

Madrigal Pharmaceuticals key executives

Madrigal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: